Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for First-Line Treatment of Patients with Squamous Non-Small Cell Lung Cancer
Business Wire•12/08/2026•09:22 ET
0
Whiz Insights
Get started
Create a free account to read the full story.